Skip to main content
. 2012 Nov;31(11):541–548. doi: 10.5732/cjc.012.10212

Figure 4. Kaplan-Meier estimates of OS (A) and DFS (B) for patients with different SPARC expression statuses.

Figure 4

Negative expression of SPARC was an adverse prognostic factor for OS (P = 0.001) but not DFS (P = 0.543). The median OS of the SPARC-negative arm was 86.9 months (95% CI: 63.2–110.7 months), but has not yet been reached for the SPARC-positive arm.